Intuitive Surgical Inc (ISRG)
367.54
-5.09
(-1.37%)
USD |
NASDAQ |
Apr 19, 11:57
Intuitive Surgical Enterprise Value: 126.94B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 126.94B |
| April 17, 2024 | 127.49B |
| April 16, 2024 | 129.04B |
| April 15, 2024 | 128.62B |
| April 12, 2024 | 131.26B |
| April 11, 2024 | 133.90B |
| April 10, 2024 | 132.56B |
| April 09, 2024 | 133.44B |
| April 08, 2024 | 132.01B |
| April 05, 2024 | 132.53B |
| April 04, 2024 | 129.17B |
| April 03, 2024 | 130.77B |
| April 02, 2024 | 130.39B |
| April 01, 2024 | 134.83B |
| March 28, 2024 | 136.32B |
| March 27, 2024 | 136.68B |
| March 26, 2024 | 135.81B |
| March 25, 2024 | 133.71B |
| March 22, 2024 | 134.54B |
| March 21, 2024 | 133.80B |
| March 20, 2024 | 133.23B |
| March 19, 2024 | 133.29B |
| March 18, 2024 | 134.03B |
| March 15, 2024 | 135.33B |
| March 14, 2024 | 131.08B |
| Date | Value |
|---|---|
| March 13, 2024 | 130.62B |
| March 12, 2024 | 132.89B |
| March 11, 2024 | 129.17B |
| March 08, 2024 | 133.76B |
| March 07, 2024 | 134.05B |
| March 06, 2024 | 132.45B |
| March 05, 2024 | 132.15B |
| March 04, 2024 | 136.86B |
| March 01, 2024 | 135.90B |
| February 29, 2024 | 131.54B |
| February 28, 2024 | 131.07B |
| February 27, 2024 | 131.03B |
| February 26, 2024 | 131.66B |
| February 23, 2024 | 132.19B |
| February 22, 2024 | 131.95B |
| February 21, 2024 | 128.83B |
| February 20, 2024 | 127.92B |
| February 16, 2024 | 128.27B |
| February 15, 2024 | 128.81B |
| February 14, 2024 | 129.37B |
| February 13, 2024 | 128.36B |
| February 12, 2024 | 129.50B |
| February 09, 2024 | 131.65B |
| February 08, 2024 | 131.20B |
| February 07, 2024 | 132.76B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
39.73B
Minimum
Mar 23 2020
136.86B
Maximum
Mar 04 2024
86.47B
Average
84.49B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 107.39B |
| Stryker Corp | 134.46B |
| Abbott Laboratories | 190.29B |
| Globus Medical Inc | 6.770B |
| Zimmer Biomet Holdings Inc | 29.98B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 606.20M |
| Revenue (Quarterly) | 1.928B |
| Total Expenses (Quarterly) | 1.478B |
| EPS Diluted (Quarterly) | 1.69 |
| Gross Profit Margin (Quarterly) | 66.24% |
| Profit Margin (Quarterly) | 31.44% |
| Earnings Yield | 1.37% |
| Operating Earnings Yield | 1.34% |
| Normalized Earnings Yield | 1.369 |